Market Brief
Ireland Growing as EU Biomanufacturing Hub, an Industrial Info Market Brief
According to the National Institute for Bioprocessing Research and Training (NIBRT), biopharma firms have invested $10 billion in Irish facilities in the past decade.
Released Thursday, March 12, 2020
According to the National Institute for Bioprocessing Research and Training (NIBRT), biopharma firms have invested $10 billion in Irish facilities in the past decade. Due to Brexit, more pharmaceutical companies are planning to move their operations to Ireland.
Industrial Info currently tracks 186 pharma plants in Ireland, with 101 projects worth $3.14 billion. Click here to see a list of projects, and see map below.
/news/article.jsp
false
Want More IIR News Intelligence?
Make us a Preferred Source on Google to see more of us when you search.
Add Us On GoogleAsk Us
Have a question for our staff?
Submit a question and one of our experts will be happy to assist you.
Forecasts & Analytical Solutions
Where global project and asset data meets advanced analytics for smarter market sizing and forecasting.
Explore Our SolutionsRelated Articles
-
Africa's Fertilizer Demand Sparks $5.8 Billion of ProjectsApril 28, 2021
-
Poland's PGE Plans $7 Billion Renewable Energy PushApril 28, 2021
-
Industrial Construction Activity Up 37% So Far in 2021April 26, 2021
Industrial Project Opportunity Database and Project Leads
Get access to verified capital and maintenance project leads to power your growth.
Discover Our DatabaseIndustry Intel
-
2026-2027 Investment Radar for Mexico, Central America & the CaribbeanPodcast Episode / May 29, 2026
-
Innovations Shaping the Next Era of Power GenerationPodcast Episode / May 22, 2026
-
The Role of Contract Manufacturing in Global Pharma GrowthPodcast Episode / May 8, 2026
-
2026 North American Labor OutlookPodcast Episode / Apr 24, 2026
-
2026 European Metals & Minerals Project Spending OutlookPodcast Episode / Apr 7, 2026